Prescriptions are required and HHS says this isn't FDA approval. No published human trials show these six peptides work for any condition.
Recap by typeshit. Full story at Yahoo.
The unapproved Lilly drug was confiscated in a dozen enforcement raids, part of a growing crackdown on gray-market retatrutide sellers.
KKM says it has seized 759 units of GLP-1 receptor agonist products worth RM405,170 since 2025 in its crackdown on unlicensed sellers.
Bhekisisa reports South Africa's regulator sees sellers on WhatsApp, Facebook and X. Inspectors close one down and another quickly takes its place.
Lincoln Journal Star reports FDA advisors are weighing whether seven unapproved peptides can be used in some compounded prescriptions.
Used needles go straight into a sharps container, which gets sealed at the fill line and kept out of household trash and recycling.
The rundown covers CagriSema, retatrutide, MariTide, VK2735 and Roche's enicepatide, which the company says cut weight by 15.5% on average in a mid-stage trial.
Loading…